Madrigal Pharmaceuticals Statistics

Total Valuation

LON:0JXI has a market cap or net worth of GBP 4.87 billion. The enterprise value is 4.34 billion.

Market Cap	4.87B
Enterprise Value	4.34B

Important Dates

The next estimated earnings date is Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	22.20M
Shares Outstanding	n/a
Shares Change (YoY)	+13.87%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	10.96M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.82
PB Ratio	8.85
P/TBV Ratio	8.91
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-14.33
EV / Sales	18.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-14.15

Financial Position

The company has a current ratio of 5.91, with a Debt / Equity ratio of 0.17.

Current Ratio	5.91
Quick Ratio	5.41
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-0.30
Interest Coverage	-30.09

Financial Efficiency

Return on equity (ROE) is -50.16% and return on invested capital (ROIC) is -29.54%.

Return on Equity (ROE)	-50.16%
Return on Assets (ROA)	-25.56%
Return on Invested Capital (ROIC)	-29.54%
Return on Capital Employed (ROCE)	-51.26%
Revenue Per Employee	465,249
Profits Per Employee	-574,026
Employee Count	528
Asset Turnover	0.31
Inventory Turnover	0.38

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.79% in the last 52 weeks. The beta is -0.76, so LON:0JXI's price volatility has been lower than the market average.

Beta (5Y)	-0.76
52-Week Price Change	+12.79%
50-Day Moving Average	295.18
200-Day Moving Average	295.53
Relative Strength Index (RSI)	62.49
Average Volume (20 Days)	58

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	12.03

Income Statement

In the last 12 months, LON:0JXI had revenue of GBP 245.65 million and -303.09 million in losses. Loss per share was -13.91.

Revenue	245.65M
Gross Profit	237.33M
Operating Income	-329.06M
Pretax Income	-303.09M
Net Income	-303.09M
EBITDA	-328.05M
EBIT	-329.06M
Loss Per Share	-13.91

Full Income Statement

Balance Sheet

The company has 652.53 million in cash and 92.70 million in debt, giving a net cash position of 559.82 million.

Cash & Cash Equivalents	652.53M
Total Debt	92.70M
Net Cash	559.82M
Net Cash Per Share	n/a
Equity (Book Value)	550.03M
Book Value Per Share	24.79
Working Capital	635.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -305.96 million and capital expenditures -855,259, giving a free cash flow of -306.82 million.

Operating Cash Flow	-305.96M
Capital Expenditures	-855,259
Free Cash Flow	-306.82M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 96.61%, with operating and profit margins of -133.95% and -123.38%.

Gross Margin	96.61%
Operating Margin	-133.95%
Pretax Margin	-123.38%
Profit Margin	-123.38%
EBITDA Margin	-133.54%
EBIT Margin	-133.95%
FCF Margin	n/a

Dividends & Yields

LON:0JXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.87%
Shareholder Yield	n/a
Earnings Yield	-6.22%
FCF Yield	-6.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0JXI has an Altman Z-Score of 9.76.

Altman Z-Score	9.76
Piotroski F-Score	n/a